Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Nashat Amir
Relationship:   Director, 10% Owner
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   51,356    

Indirect Shares

   3,062,595      
Direct Value   $461,312    

Indirect Value

   $5,463,098      
Total Shares   3,113,951      
Total Value   $5,924,410      


aTyr Pharma Inc $4,606 Scholar Rock Holding Corp $452,463 Morphic Holding, Inc. $4,243 aTyr Pharma Inc $4,606 Scholar Rock Holding Corp $452,463 Morphic Holding, Inc. $4,243
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   1.0   
   -1.0   
     Percentage Gain/Loss :
   89.2%
 -3.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Receptos, Inc. RCPT Director 2013-05-14 0 2014-05-27 274    Premium*  
            Fate Therapeutics Inc FATE Director 2013-10-04 0 2019-08-01 11,034    Premium*  
            aTyr Pharma Inc LIFE Former 10% Owner, Dire... 2015-05-12 12,572 2015-05-12 17,638    Premium*  
            Selecta Biosciences Inc SELB Director 0 2019-01-25 2,676,234    Premium*  
            Syros Pharmaceuticals, Inc. SYRS Director, 10% Owner 2016-07-06 0 2016-07-06 48,320    Premium*  
            Scholar Rock Holding Corp SRRK 2024-05-09 38,639 2024-05-09 0    Premium*  
            Morphic Holding, Inc. MORF Director 2023-06-28 145 2023-06-28 130,153    Premium*  
            Metacrine, Inc. MTCR Director, 10% Owner 2020-09-18 0 2020-09-18 178,942    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
MORF Morphic Holding, Inc. Director   –       •      –    2021-05-21 4 S $45.50 $10,569,423 I/I (232,295) 136,691 0 %
RCPT Receptos, Inc. Director   –       •      –    2013-05-14 4 OE $7.73 $8,005,165 I/I 1,035,597 1,035,597 0 -
FATE Fate Therapeutics Inc Director   –       •      –    2018-12-12 4 S $16.78 $7,132,690 I/I (425,000) 1,965,658 0 -
SRRK Scholar Rock Holding Corp Director   –       •      –    2022-06-22 4 B $4.90 $5,870,161 I/I 1,197,992 206,897 2.1 %
SYRS Syros Pharmaceuticals, In... Director   –       •       •   2016-07-06 4 B $12.50 $5,000,000 I/I 400,000 48,320 2.25 -
FATE Fate Therapeutics Inc Director   –       •       •   2013-10-04 4 B $6.00 $4,999,998 I/I 833,333 2,473,186 2.25 -
RCPT Receptos, Inc. Director   –       •      –    2013-12-06 4 S $26.69 $4,538,860 I/I (170,000) 46,851 0 -
RCPT Receptos, Inc. Director   –       •      –    2013-11-14 4/A S $25.00 $3,852,225 I/I (154,089) 1,032,851 0 -
RCPT Receptos, Inc. Director   –       •      –    2013-11-14 4 S $25.00 $3,852,225 I/I (154,089) 1,032,001 0 -
RCPT Receptos, Inc. Director   –       •      –    2013-11-14 4/A S $25.00 $3,852,225 I/I (154,089) 58,772 0 -
MTCR Metacrine, Inc. Director   –       •       •   2020-09-18 4 B $13.00 $2,990,000 I/I 230,000 15,038 2.25 -
RCPT Receptos, Inc. Director   –       •      –    2013-05-14 4 B $14.00 $2,118,802 I/I 151,343 1,186,940 2.1 -
SELB Selecta Biosciences Inc Director   –       •       •   2016-06-27 4 B $14.00 $2,100,000 I/I 150,000 1,836,703 2.25 -
SELB Selecta Biosciences Inc Director   –       •      –    2017-09-21 4 S $19.86 $2,076,826 I/I (104,577) 1,694,676 0 -
FATE Fate Therapeutics Inc Director   –       •      –    2019-07-30 4 AS $22.51 $2,029,560 I/I (90,175) 11,635 0 -
SRRK Scholar Rock Holding Corp Director   –       •       •   2018-05-29 4 B $14.00 $1,999,998 I/I 142,857 156,395 2.25 -
MORF Morphic Holding, Inc. Director   –       •      –    2019-07-01 4 B $15.00 $1,875,000 I/I 125,000 151,879 2.1 -
SELB Selecta Biosciences Inc Director   –       •      –    2019-01-25 4 B $1.50 $1,749,999 I/I 1,166,666 2,676,234 2.1 -
FATE Fate Therapeutics Inc Director   –       •      –    2019-07-23 4 AS $22.51 $1,396,053 I/I (62,033) 12,973 0 -
FATE Fate Therapeutics Inc Director   –       •      –    2019-01-29 4 S $14.16 $1,380,795 I/I (97,500) 1,526,203 0 -
FATE Fate Therapeutics Inc Director   –       •      –    2018-12-11 4 S $16.71 $1,379,183 I/I (82,528) 2,390,658 0 -
SELB Selecta Biosciences Inc Director   –       •      –    2017-09-26 4 S $18.91 $1,328,079 I/I (70,226) 1,550,478 0 -
FATE Fate Therapeutics Inc Director   –       •      –    2019-01-25 4 S $14.14 $1,272,753 I/I (90,000) 1,693,703 0 -
FATE Fate Therapeutics Inc Director   –       •      –    2018-12-19 4 S $13.17 $1,222,592 I/I (91,210) 1,856,660 0 -
FATE Fate Therapeutics Inc Director   –       •      –    2019-07-22 4 AS $22.52 $1,097,019 I/I (48,704) 13,574 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us